Cargando…

Should We Offer In Vitro Fertilization to Couples with Unexplained Recurrent Pregnancy Loss?

In clinical practice, empirical treatments are often offered to couples with recurrent pregnancy loss, including in vitro fertilization. Given that most patients with recurrent pregnancy loss are fertile, the scientific rationale of in vitro fertilization for these couple is debatable. This review w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirshenbaum, Michal, Orvieto, Raoul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912379/
https://www.ncbi.nlm.nih.gov/pubmed/31744073
http://dx.doi.org/10.3390/jcm8112001
_version_ 1783479442115395584
author Kirshenbaum, Michal
Orvieto, Raoul
author_facet Kirshenbaum, Michal
Orvieto, Raoul
author_sort Kirshenbaum, Michal
collection PubMed
description In clinical practice, empirical treatments are often offered to couples with recurrent pregnancy loss, including in vitro fertilization. Given that most patients with recurrent pregnancy loss are fertile, the scientific rationale of in vitro fertilization for these couple is debatable. This review will discuss the potential benefits of using in vitro fertilization in couples with recurrent pregnancy loss, such as shortening the time to conceive, optimizing the timing of conception, improving gamete and embryo quality, endometrial receptivity and the use of “adds-on”. At present, there is not enough evidence to justify IVF as a treatment option in couples with unexplained recurrent pregnancy loss.
format Online
Article
Text
id pubmed-6912379
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69123792020-01-02 Should We Offer In Vitro Fertilization to Couples with Unexplained Recurrent Pregnancy Loss? Kirshenbaum, Michal Orvieto, Raoul J Clin Med Review In clinical practice, empirical treatments are often offered to couples with recurrent pregnancy loss, including in vitro fertilization. Given that most patients with recurrent pregnancy loss are fertile, the scientific rationale of in vitro fertilization for these couple is debatable. This review will discuss the potential benefits of using in vitro fertilization in couples with recurrent pregnancy loss, such as shortening the time to conceive, optimizing the timing of conception, improving gamete and embryo quality, endometrial receptivity and the use of “adds-on”. At present, there is not enough evidence to justify IVF as a treatment option in couples with unexplained recurrent pregnancy loss. MDPI 2019-11-16 /pmc/articles/PMC6912379/ /pubmed/31744073 http://dx.doi.org/10.3390/jcm8112001 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kirshenbaum, Michal
Orvieto, Raoul
Should We Offer In Vitro Fertilization to Couples with Unexplained Recurrent Pregnancy Loss?
title Should We Offer In Vitro Fertilization to Couples with Unexplained Recurrent Pregnancy Loss?
title_full Should We Offer In Vitro Fertilization to Couples with Unexplained Recurrent Pregnancy Loss?
title_fullStr Should We Offer In Vitro Fertilization to Couples with Unexplained Recurrent Pregnancy Loss?
title_full_unstemmed Should We Offer In Vitro Fertilization to Couples with Unexplained Recurrent Pregnancy Loss?
title_short Should We Offer In Vitro Fertilization to Couples with Unexplained Recurrent Pregnancy Loss?
title_sort should we offer in vitro fertilization to couples with unexplained recurrent pregnancy loss?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912379/
https://www.ncbi.nlm.nih.gov/pubmed/31744073
http://dx.doi.org/10.3390/jcm8112001
work_keys_str_mv AT kirshenbaummichal shouldweofferinvitrofertilizationtocoupleswithunexplainedrecurrentpregnancyloss
AT orvietoraoul shouldweofferinvitrofertilizationtocoupleswithunexplainedrecurrentpregnancyloss